Oropharynx/Hypopharynx/nasopharynx/oralcavity Flashcards

1
Q

Anatomy of the oral cavity (subdivisions)

A

Extends from the skin-vermilion junction of the lip to the posterior border of the hard palate.

Subdivisions include:

  • anterior two/thirds of the tongue
  • lip
  • buccal mucosa
  • retromolar trigone
  • floor of the mouth
  • hard palate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical presentation of oral cancer

A
  • poor oral/dental hygiene
  • Plummer-Vinson syndrome (iron-deficiency anemia) is considered a risk factor in women
  • leukoplakia and erythroplasia are considered serious pathologic problems.
  • most oral cavity cancers present as non-healing lesions
  • pain may be associated with advanced disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Radiation therapy for oral cavity

A

Local regional control depends on highly accurate treatment with a sharp dose gradient to reduce the dose to surrounding healthy tissue.

The gross disease will receive a dose of approximately 70Gy

Volumes at high risk for microscopic disease and high-risk lymph nodes receive a dose of 64Gy

Volumes of low risk such as contralateral neck and elective lymph nodes should receive 60Gy

Electron treatment can be used for treatment areas such as lip or superficial tumours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The natural history of oral cancer

A
  • oral cavity cancers have the lowest incidence (except glottic tumours) of nodal spread for all head and neck cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharynx anatomy

A

Subdivided into three sections:

  • oropharynx
  • nasopharynx
  • hypopharynx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Oropharynx anatomy

A

Consists of the base of the tongue, the tonsils, the soft palate and the oropharyngeal wall.

Situated between C3 and the axis

Located behind the mouth from the soft palate above to the hyoid bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anatomy of the hypopharynx

A

Composed of the pyriform sinuses, post-cricoid and lower posterior pharyngeal walls.

Anatomically situated between C3 and C6.

Cricoid cartilage represents the inferior border and the epiglottis the superior border.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Epidemiology for hypopharynx cancer

A

Male to female rate ranges from 5:1 to 7:1 for pyriform sinus cancer

Male to female rate ranges from 3:1 to 4:1 for pharyngeal wall cancer

Postcricoid cancers are typically female

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Signs and symptoms of pharynx cancer

A

Sore throat and pain when swallowing is most common.

Otalagia (ear pain) can also occur

Enlargement of the cervical nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Common presenting symptoms of hypopharynx cancer

A
  • sore throat
  • odynophagia
  • 25% present with a neck mass

Dysphagia and weight loss are more common in advanced diseases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Etiology of oral cavity or oropharynx cancers

A

Growing subpopulation between 20 and 50 due to the rising incidence of HPV-related head and neck cancers.

50-60-year-old with a long history of smoke &/or alcohol consumption

  • more than 20 cigs/day increase 6-fold risk
  • 6oz liquor day increase 10-fold risk

Chewing betel nut, smokeless tobacco-related to buccal mucosa, lip and floor of mouth (more common in Asia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Highest site of incidence for hypopharynx cancer

A

Pyriform sinus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Radiation therapy for the oropharynx region

A

Early T1 and T2 lesions are treatable with EBRT alone

Large volumes are required T3 and T4 lesions that encompass the cervical and supraclavicular nodes.

Stage III and IV cancers are treated with definitive radiation and concurrent chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of hypopharynx cancer

A

Typically an advanced disease. With high rates of nodal metastasis for pyriform sinus cancers.

Rare T1 and T2 lesions can be treated with radiation therapy or surgery and are curable.

T2-T4 lesions are more common and are not candidates for laryngeal preservation surgery. Most patients receive combined radical surgery and radiation therapy. Large radiation therapy fields are needed to treat pyriform sinus as well as cervical lymph nodes.

Tumours of the posterior pharyngeal wall are unresectable and are treated with large field RT. That includes the entire pharynx, upper cervical esophagus, extending superiorly to the nasopharynx vault and local lymph nodes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Radiation therapy for the pharynx region

A

Radiation therapy has become the standard of treatment for oropharynx cancer.

As cure rates increase the concern for treatment-related issues such as xerostomia and mandible necrosis has become important issues.

IMRT helps to reduce the dose to organs at risk and help with locoregional control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pathology of pharynx cancers

A

Predominantly SCC (90%)

Lymphoepilioma may occur in the tonsil and the base of the tongue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Negative prognosis indicators for all head and neck cancers

A

Tumours that cross the midline

Invasion of lamina propria or submucosa

Poorly differentiated

Non-SCC

Fixed lymph nodes

Cranial nerve involvement

Vascular invasion

18
Q

Nasopharynx anatomy

A

Includes the:

  • posterosuperior pharyngeal wall
  • lateral pharyngeal wall
  • eustachian tube orifice
  • adenoids

Location: lies on a line from the zygomatic arch to the external auditory meatus extending inferiorly to the mastoid tip. Lies behind the nasal cavity and above the level of the soft palate.

19
Q

Epidemiology of nasopharynx cancer

A

The age distribution is bimodal with a small peak in adolescence and young adulthood but with a large peak between 50-70 years of age.

Uncommon in white populations (accounts for only 2% of cases)

The high incidence rate in southern Chinese (57%) and middle eastern countries may be attributed to nitrosamines in alsed fish.

20
Q

Lymph spread from the nasopharynx

A
  • Retropharyngeal
  • upper jugular
  • spinal accessory
21
Q

Etiology of nasopharynx cancer

A

Not associated with tobacco

Associated with EBV

22
Q

Pathology of nasopharynx cancer

A

The tendency toward poor differentiation and unusual growth patterns.

Type 1: keratinizing SCC (20% of cases)

Type 2: non-keratinizing SCC (10% of cases)

Type 3: lymphepithelioma (poorly differentiated carcinomas, 70% of cases)

23
Q

Radiation therapy for nasopharynx cancer

A

Due to the high likelihood of involvement of the cervical nodes and local spread radiation fields are typically large.

Concern due to a high number of OAR’s in the area makes it difficult to provide the high dose needed to control the disease.

The CTV should include the GTV as well as the high-risk nodes including:

  • upper deep jugular nodes
  • submandibular nodes
  • subdigastric nodes
  • mid jugular nodes
  • posterior cervical nodes
  • retropharyngeal nodes

* adjuvant chemotherapy seems to improve both local control and survival. Chemotherapy should be used with stage III and IV tumours.

24
Q

Location of metastasis for nasopharynx cancer

A

25% chance of bloodborne metastasis

In those with bilateral cervical nodes 40-70% chance of distant metastasis.

Bone, lung and liver being most common.

25
Q

Nasopharynx T1 stage

A

Tumour confined to nasopharynx or extends to oropharynx or nasal cavity without parapharyngeal extension.

26
Q

Nasopharynx T2 stage

A

Tumour involves parapharyngeal extension

27
Q

Nasopharynx T3 stage

A

Tumour involves bony structures of skull base or paranasal sinuses

28
Q

Nasopharynx T4 stage

A

Tumour with intracranial extension or involvement of cranial nerves, hypopharynx, or orbit, or with extension to the infratemporal fossa

29
Q

Hypopharynx T1 stage

A

Tumour limited to one subsite of the hypopharynx or 2cm or less in greatest dimension

30
Q

Hypopharynx T2 stage

A

Tumour invades more than one subsite of the hypopharynx or an adjacent site or measures more than 2cm but not more than 4cm in greatest dimension without fixation of the hemilarynx.

31
Q

Hypopharynx T3 stage

A

Tumour more than 4cm in greatest dimension or with fixation of hemilarynx or extension into the esophagus.

32
Q

Hypopharynx T4 stages

A

T4a: moderately advanced local disease.

  • tumour invades thyroid/cricoid cartilage, hyoid bone, thyroid gland

T4b: very advanced local disease

  • Tumour invades prevertebral fascia, encases carotid artery, or involves mediastinal structures.
33
Q

Oropharynx T1 stage

A

Tumour 2cm or less in dimension

34
Q

Oropharynx T2 stage

A

Tumour more then 2cm but less then 4cm in the greatest dimension

35
Q

Oropharynx T3 stage

A

Tumour more than 4cm in greatest dimension or extension to the lingual surface of glottis

36
Q

Oropharynx T4 stages

A

T4a: Moderately advanced local disease

  • tumour invades larynx, extrinsic muscle of tongue, hard palate or mandible

T4b: very advanced local disease

  • tumour invades the lateral nasopharynx, skull base or encases carotid artery.
37
Q

Nasopharynx N1 stage

A

Unilateral metastasis in lymph nodes, 6cm or less in greatest dimension, above the supraclavicular fossa or unilateral or bilateral retropharyngeal nodes 6cm or less in greatest dimension.

38
Q

Nasopharynx N2 stage

A

Bilateral metastasis in lymph nodes <6cm in dimension above supraclavicular fossa

39
Q

Nasopharynx N3 stages

A

N3: metastasis in lymph nodes >6cm in dimension or extension into the supraclavicular fossa

N3a: >6cm in greatest dimension

N3b: extension into the supraclavicular fossa

40
Q

Oropharynx and hypopharynx N1 stage

A

Metastasis in a single ipsilateral lymph node 3cm or less in greatest dimension

41
Q

Oropharynx and hypopharynx N2 stage

A

N2a: metastasis in a single lymph node more than 3cm but less than 6cm in greatest dimension

N2b: metastasis in multiple ipsilateral lymph nodes, none more than 6cm in greatest dimension

N2c: metastasis in bilateral or contralateral lymph nodes, none more then 6cm in greatest dimension

42
Q

Oropharynx and hypopharynx N3 stage

A

Metastasis in a lymph node more then 6cm in greatest dimension